ETrade Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

ETrade Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$603K	Sell	7,767 -21,108	-73%	-$1.45M	0.01%	515
2020 Q2	$1.6M	Buy	28,875 +906	+3%	+$38.8K	0.03%	240
2020 Q1	$828K	Buy	+27,969	New	+$946K	0.02%	343
2019 Q2	–	Sell	-21,706	Closed	-$574K	–	862
2019 Q1	$574K	Sell	21,706 -53,446	-71%	-$1.27M	0.02%	484
2018 Q4	$1.47M	Buy	75,152 +1,997	+3%	+$39.1K	0.05%	218
2018 Q3	$1.43M	Buy	73,155 +62,828	+608%	+$1.19M	0.04%	253
2018 Q2	$171K	Buy	+10,327	New	+$157K	0.01%	765
2017 Q4	–	Sell	-50,590	Closed	-$641K	–	777
2017 Q3	$641K	Buy	+50,590	New	+$643K	0.02%	408

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

ETrade Capital Management's HZNP Position: Q3 2020 in Review

ETrade Capital Management reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 73% in Q3 2020, selling an estimated $1.45M and leaving 7,767 shares worth $603K. The position accounts for 0.01% of the portfolio, ranked #515.

ETrade Capital Management first reported a position in HZNP in Q3 2017 and has held it in 8 quarters since. The position peaked at $1.6M in Q2 2020. 433 funds tracked by Wall St. Rank hold HZNP as of Q3 2020.

ETrade Capital Management held 7,767 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $603K as of Q3 2020.
ETrade Capital Management sold 21,108 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2020, an estimated $1.45M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.01% of ETrade Capital Management's portfolio in Q3 2020, its #515 holding.
ETrade Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2017 and has held it in 8 quarters since.
ETrade Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.6M in Q2 2020.
433 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.